Boehringer Ingelheim: Leading the Charge Against Stroke in MEA
With a legacy spanning 130 years as one of the world’s leading research-driven biopharmaceutical companies, Boehringer Ingelheim’s Middle East & Africa (MEA) operations are headquartered in Dubai. The company also maintains scientific offices in Egypt, Saudi Arabia, and Algeria, with its footprint extending into East Africa through Nairobi. In 2023,
